Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001934050 | SCV002211110 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2022-07-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002562120 | SCV003527465 | uncertain significance | Inborn genetic diseases | 2022-04-25 | criteria provided, single submitter | clinical testing | The c.2150C>T (p.S717L) alteration is located in exon 10 (coding exon 9) of the CACNA1H gene. This alteration results from a C to T substitution at nucleotide position 2150, causing the serine (S) at amino acid position 717 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |